Top news
Moderna COVID-19 vaccine slightly more effective | News | Harvard T.H. Chan School of Public Health
FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly
By Manojna Maddipatla, Anil Dsilva & Krishna Chandra Eluri
New Harvard study declares winner between Pfizer and Moderna vaccines
By Alejandra O'connell
All coverage
Pfizer could have vaccine data for kids under age 5 by year-end, CEO says
By Berkeley Lovelace & Berkeley Lovelace Jr.
COVID-19 booster side effects: What to expect
By Sarah Jacoby
Moderna vaccine slightly more effective than Pfizer
By Nicole Giese Rura
Moderna exec says company could have Omicron booster ready in March
By Michael Erman & Julie Steenhuysen